🇺🇸 FDA
Pipeline program

Tralesinidase alfa (TA)

250-301

Phase 3 small_molecule active

Quick answer

Tralesinidase alfa (TA) for MPS IIIB is a Phase 3 program (small_molecule) at SPRUCE BIOSCIENCES, INC. with 1 ClinicalTrials.gov record(s).

Program details

Company
SPRUCE BIOSCIENCES, INC.
Indication
MPS IIIB
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials